NCT00025376 - PS-341 in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

September 30, 2002

Study Completion Date

March 31, 2006

Conditions

Kidney Cancer

Interventions

DRUG

PS-341

PROCEDURE

Tumor Biopsy

Trial Locations (10)

Michiana Hematology/Oncology P.C., South Bend

Oncology Care Associates, P.L.L.C., Saint Joseph

Loyola University Medical Center, Maywood

Ingalls Memorial Hospital, Harvey

LaGrange Memorial Hospital, LaGrange

Louis A. Weiss Memorial Hospital, Chicago

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

Cancer Care Specialists of Central Illinois, S.C., Decatur

University of Chicago Cancer Research Center, Chicago

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER